NCT04860921 is a clinical trial in Zinc Deficiency, sponsored by Assiut University.

Who is sponsoring NCT04860921?

NCT04860921 is sponsored by Assiut University.

What condition does NCT04860921 study?

NCT04860921 studies Zinc Deficiency.

Is NCT04860921 still recruiting?

NCT04860921 is currently status unknown. Last updated 27 April 2021.

Last reviewed 2021-04-27 · How we verify

NCT04860921

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Zinc Deficiency in Dilated Cardiomyopathy

Status unknown Last updated 27 April 2021

What this trial tests

trial in Zinc Deficiency in 50 participants. Status unknown.

Timeline

20 April 2021

Primary endpoint
20 November 2022

28 December 2022

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	20 April 2021
Primary completion	20 November 2022
Estimated completion	28 December 2022

Conditions studied

Zinc Deficiency — all drugs for Zinc Deficiency →

Sponsor

Assiut University

Who can join

Adults 1 to 18, any sex, with Zinc Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to detect effect of oral zinc supplementation in pediatric patients with dilated cardiomyopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Zinc Deficiency

Currently open trials in the same condition.

NCT06219525 — Higher and Standard Doses of Enteral Zinc Supplementation in Very Preterm Infants · NA · recruiting
NCT05236374 — Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc · NA · recruiting
NCT04694235 — Egg Intervention During Pregnancy in Indonesia · NA · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04860921 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 27 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04860921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing